Literature DB >> 30919885

Modeling Regional Transmission and Containment of a Healthcare-associated Multidrug-resistant Organism.

Prabasaj Paul1, Rachel B Slayton1, Alexander J Kallen1, Maroya S Walters1, John A Jernigan1.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention (CDC) recently published interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). We assessed the impact of implementing the strategy in a US state using a mathematical model.
METHODS: We used a deterministic compartmental model, parametrized via a novel analysis of carbapenem-resistant Enterobacteriaceae data reported to the National Healthcare Safety Network and patient transfer data from the Centers for Medicare and Medicaid Services. The simulations assumed that after the importation of the MDRO and its initial detection by clinical culture at an index hospital, fortnightly prevalence surveys for colonization and additional infection control interventions were implemented at the index facility; similar surveys were then also implemented at those facilities known to be connected most strongly to it as measured by patient transfer data; and prevalence surveys were discontinued after 2 consecutive negative surveys.
RESULTS: If additional infection-control interventions are assumed to lead to a 20% reduction in transmissibility in intervention facilities, prevalent case count in the state 3 years after importation would be reduced by 76% (interquartile range: 73-77%). During the third year, these additional infection-control measures would be applied in facilities accounting for 42% (37-46%) of inpatient days.
CONCLUSIONS: CDC guidance for containing MDROs, when used in combination with information on transfer of patients among hospitals, is predicted to be effective, enabling targeted and efficient use of prevention resources during an outbreak response. Even modestly effective infection-control measures may lead to a substantial reduction in transmission events. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  healthcare epidemiology; mathematical model; multidrug-resistant organism

Mesh:

Year:  2020        PMID: 30919885      PMCID: PMC6765447          DOI: 10.1093/cid/ciz248

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.

Authors:  Alice Y Guh; Sandra N Bulens; Yi Mu; Jesse T Jacob; Jessica Reno; Janine Scott; Lucy E Wilson; Elisabeth Vaeth; Ruth Lynfield; Kristin M Shaw; Paula M Snippes Vagnone; Wendy M Bamberg; Sarah J Janelle; Ghinwa Dumyati; Cathleen Concannon; Zintars Beldavs; Margaret Cunningham; P Maureen Cassidy; Erin C Phipps; Nicole Kenslow; Tatiana Travis; David Lonsway; J Kamile Rasheed; Brandi M Limbago; Alexander J Kallen
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

2.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.

Authors:  Mitchell J Schwaber; Boaz Lev; Avi Israeli; Ester Solter; Gill Smollan; Bina Rubinovitch; Itamar Shalit; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2011-02-11       Impact factor: 9.079

3.  2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.

Authors:  Ikwo K Oboho; Sara M Tomczyk; Ahmad M Al-Asmari; Ayman A Banjar; Hani Al-Mugti; Muhannad S Aloraini; Khulud Z Alkhaldi; Emad L Almohammadi; Basem M Alraddadi; Susan I Gerber; David L Swerdlow; John T Watson; Tariq A Madani
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

Review 4.  Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.

Authors:  Alice Y Guh; Brandi M Limbago; Alexander J Kallen
Journal:  Expert Rev Anti Infect Ther       Date:  2014-03-25       Impact factor: 5.091

5.  The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.

Authors:  Damon J A Toth; Karim Khader; Rachel B Slayton; Alexander J Kallen; Adi V Gundlapalli; Justin J O'Hagan; Anthony E Fiore; Michael A Rubin; John A Jernigan; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

6.  The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

Authors:  Bruce Y Lee; Sarah M Bartsch; Kim F Wong; James A McKinnell; Rachel B Slayton; Loren G Miller; Chenghua Cao; Diane S Kim; Alexander J Kallen; John A Jernigan; Susan S Huang
Journal:  Am J Epidemiol       Date:  2016-02-08       Impact factor: 4.897

7.  Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.

Authors:  Kate Russell Woodworth; Maroya Spalding Walters; Lindsey M Weiner; Jonathan Edwards; Allison C Brown; Jennifer Y Huang; Sarah Malik; Rachel B Slayton; Prabasaj Paul; Catherine Capers; Marion A Kainer; Nancy Wilde; Alicia Shugart; Garrett Mahon; Alexander J Kallen; Jean Patel; L Clifford McDonald; Arjun Srinivasan; Michael Craig; Denise M Cardo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-04-06       Impact factor: 17.586

8.  Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study.

Authors:  Gerardo Chowell; Fatima Abdirizak; Sunmi Lee; Jonggul Lee; Eunok Jung; Hiroshi Nishiura; Cécile Viboud
Journal:  BMC Med       Date:  2015-09-03       Impact factor: 8.775

  8 in total
  7 in total

1.  Identifying asymptomatic spreaders of antimicrobial-resistant pathogens in hospital settings.

Authors:  Sen Pei; Fredrik Liljeros; Jeffrey Shaman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

2.  Dual-Function Potentiation by PEG-BPEI Restores Activity of Carbapenems and Penicillins against Carbapenem-Resistant Enterobacteriaceae.

Authors:  Hannah Panlilio; Anh K Lam; Neda Heydarian; Tristan Haight; Cassandra L Wouters; Erika L Moen; Charles V Rice
Journal:  ACS Infect Dis       Date:  2021-05-04       Impact factor: 5.084

Review 3.  Modeling transmission of pathogens in healthcare settings.

Authors:  Anna Stachel; Lindsay T Keegan; Seth Blumberg
Journal:  Curr Opin Infect Dis       Date:  2021-08-01       Impact factor: 4.968

4.  Pharmacist-Driven Antibiotic Stewardship Program in Febrile Neutropenic Patients: A Single Site Prospective Study in Thailand.

Authors:  Kittiya Jantarathaneewat; Anucha Apisarnthanarak; Wasithep Limvorapitak; David J Weber; Preecha Montakantikul
Journal:  Antibiotics (Basel)       Date:  2021-04-17

5.  regentrans: a framework and R package for using genomics to study regional pathogen transmission.

Authors:  Sophie Hoffman; Zena Lapp; Joyce Wang; Evan S Snitkin
Journal:  Microb Genom       Date:  2022-01

6.  Combating Antimicrobial Resistance: Going Beyond New Antibiotics.

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2020-09-09       Impact factor: 3.393

7.  The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.

Authors:  Mabel Duarte Alves Gomides; Astrídia Marília de Souza Fontes; Amanda Oliveira Soares Monteiro Silveira; Daniel Chadud Matoso; Anderson Luiz Ferreira; Geraldo Sadoyama
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.